Lasa Supergenerics spurts after Mahad unit gets WHO-GMP

Lasa Supergenerics rose 5.98% to Rs 93 at 9:43 IST on BSE after the company said it received WHO-GMP certificate for unit situated at Mahad, Maharashtra.

The announcement was made after market hours yesterday, 19 April 2018.

Meanwhile, the S&P BSE Sensex was down 78.44 points, or 0.23% to 34,348.85.

On the BSE, 13,000 shares were traded in the counter so far compared with average daily volumes of 29,000 shares in the past two weeks. The stock had hit a high of Rs 94.65 and a low of Rs 92.30 so far during the day. The stock hit a record high of Rs 214.90 on 4 January 2018. The stock hit a record low of Rs 83.80 on 13 March 2018.

Lasa Supergenerics announced that it received World Health Organisation (WHO) Good Manufacturing Practice (GMP) Certificate for unit situated at Mahad issued by the office The Commissioner the Food and Drug Administration. Entry to regulated business markets to commence shortly, the company added.

Lasa Supergenerics reported net profit of Rs 3.11 crore on net sales of Rs 60.99 crore in the quarter ended December 2017.

Lasa Supergenerics is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chainfrom discovery-to-delivery, with established credentials in research, manufacturing and global marketing.

Powered by Capital Market - Live News